Bourdin, Aline http://orcid.org/0000-0002-1331-4557
Dubois, Julie http://orcid.org/0000-0001-9241-0231
Foley, Rose-Anna http://orcid.org/0000-0001-5928-2928
Schluep, Myriam
Bugnon, Olivier http://orcid.org/0000-0003-2249-1245
Berger, Jérôme http://orcid.org/0000-0003-1177-5453
Article History
Received: 29 October 2019
Accepted: 30 April 2020
First Online: 14 May 2020
Ethics approval and consent to participate
: A protocol was submitted to the cantonal commission for the ethics of human research (CER-VD), which stated that no formal ethical approval for this study was legally required (Req-2017-00035), as there was no collection of personal health-related data. However, all procedures performed in this study were in accordance with the ethical standards of the local ethics committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Each participant signed a written consent form to participate in the study.
: Not applicable.
: OB is a member of the advisory board of SISPha SA. MS has served as a consultant for Merck-Serono and has received honoraria, payment for the development of educational presentations, and travel support from Merck-Serono, Biogen Idec, Novartis, Sanofi-Aventis, Bayer Schering, Roche and Genzyme. The other authors declare that they have no competing interests.